DexCom (Germany) Top Insiders
| DC4 Stock | EUR 73.54 0.92 1.24% |
DexCom employs about 7.5 K people. The company is managed by 10 executives with a total tenure of roughly 17500 years, averaging almost 1750.0 years of service per executive, having 750.0 employees per reported executive. Examination of DexCom's management performance can provide insight into the company performance.
| Kevin Sayer Insider CEO Chairman |
| Matthew Dolan Insider Corp Strategy |
DexCom |
DexCom Management Team Effectiveness
The company has return on total asset (ROA) of 0.0474 % which means that it generated a profit of $0.0474 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1635 %, meaning that it generated $0.1635 on every $100 dollars invested by stockholders. DexCom's management efficiency ratios could be used to measure how well DexCom manages its routine affairs as well as how well it operates its assets and liabilities.DexCom Workforce Comparison
DexCom Inc is one of the top stocks in number of employees category among its peers. The total workforce of Diagnostics & Research industry is currently estimated at about 36,573. DexCom totals roughly 7,500 in number of employees claiming about 21% of equities under Diagnostics & Research industry.
The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13. DexCom Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. DexCom Inc Price Series Summation is a cross summation of DexCom price series and its benchmark/peer.
DexCom Notable Stakeholders
A DexCom stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as DexCom often face trade-offs trying to please all of them. DexCom's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting DexCom's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kevin Sayer | CEO Chairman | Profile | |
| Matthew Dolan | Corp Strategy | Profile | |
| Michael Brown | Ex Officer | Profile | |
| Jacob Leach | Ex COO | Profile | |
| Sadie Stern | Ex Officer | Profile | |
| Jereme Sylvain | CFO VP | Profile | |
| Sean Christensen | Director Relations | Profile | |
| Steven Pacelli | Ex Ventures | Profile | |
| Andrew Balo | Access Affairs | Profile | |
| Paul Flynn | Ex Revenue | Profile |
About DexCom Management Performance
The success or failure of an entity such as DexCom Inc often depends on how effective the management is. DexCom management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of DexCom management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the DexCom management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California. DEXCOM INC operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2800 people.
DexCom Workforce Analysis
Traditionally, organizations such as DexCom use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare DexCom within its industry.DexCom Manpower Efficiency
Return on DexCom Manpower
| Revenue Per Employee | 388K | |
| Revenue Per Executive | 291M | |
| Net Income Per Employee | 45.5K | |
| Net Income Per Executive | 34.1M |
Complementary Tools for DexCom Stock analysis
When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |